Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.
about
Clinical use of pasireotide for Cushing's disease in adultsThe Treatment of Cushing's Disease.Update on medical treatment for Cushing's disease.Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialItalian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Effectiveness of low-dose pasireotide in a patient with Cushing's disease: antiproliferative effect and predictivity of a short pasireotide suppression test.Diabetes Mellitus Secondary to Cushing's Disease.
P2860
Q26858933-778F2703-A89D-40A8-9868-737B1B61961BQ27010590-42A99A9E-E5FB-4BB8-8E47-A8EBF01448BCQ33802284-D906E444-0C3E-4BBB-A949-D727EAD5035DQ33840655-0F293A77-B01B-4FFB-98E9-A9DEA10D7A41Q38683309-2147C580-1649-4284-9C45-7F86F7317A59Q42911830-53B41E06-A306-4EA0-8FDD-1C8FDEA4DC09Q55425212-F5ED3C59-561B-4D20-B3C5-124B887E7869
P2860
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Up-to 5-year efficacy of pasir ...... nical practice considerations.
@en
type
label
Up-to 5-year efficacy of pasir ...... nical practice considerations.
@en
prefLabel
Up-to 5-year efficacy of pasir ...... nical practice considerations.
@en
P2093
P2860
P1433
P1476
Up-to 5-year efficacy of pasir ...... inical practice considerations
@en
P2093
Carolina Concettoni
Giorgia Marcelli
Giorgio Arnaldi
Laura Trementino
Marina Cardinaletti
P2860
P2888
P304
P356
10.1007/S11102-014-0582-9
P577
2015-06-01T00:00:00Z